Lack of efficacy of levocarnitine for the treatment of pegylated asparaginase-related hepatotoxicity during induction or salvage chemotherapy in adults with acute lymphoblastic leukemia: A comparative, retrospective, University of California hematologic malignancies consortium (UCHMC) study
Year: 2025
Type: conference-abstract
Source: Blood
Institutions: Wake Forest University Health Sciences, Wake Forest University, Johnson & Johnson (United States), University of California, Los Angeles, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Mass General Brigham, University of California, San Francisco, Kaiser Permanente Santa Clara Medical Center, Tulane University, University of California, Irvine, University of California, Irvine Medical Center, University of California, Davis, University of Washington, Fred Hutch Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417019179
Cites:
Cited by:
Related to: